Log in or Sign up for Free to view tailored content for your specialty!
ADD/ADHD News
Half of young people with ADHD receive antipsychotics without proper indication
Approximately half of youth who received antipsychotics during the year after an ADHD diagnosis had a diagnosis for which antipsychotics are indicated, and less than half of these youth received a stimulant — the evidence-supported first-line ADHD treatment, study data revealed.
Massachusetts General ranked #1 hospital for psychiatry in 2019 to 2020
Massachusetts General Hospital has been named the number one hospital for psychiatric care in America for 2019 to 2020, according to the U.S. News & World Report.
Log in or Sign up for Free to view tailored content for your specialty!
FDA warns company for selling unapproved CBD products to treat Alzheimer’s, cancer, opioid withdrawal
The FDA has issued a warning letter to Curaleaf Inc. for illegally selling unapproved products containing cannabidiol, or CBD, online, claiming to treat Alzheimer’s disease, cancer, opioid withdrawal, pain and other conditions, according to a press release.
Stimulant treatment prevents ADHD-related functional complications
Treatment with stimulant medications in children with ADHD was linked to a lower risk for functional complications mood, conduct and substance use disorders, and school problems, study findings published in Journal of Adolescent Health revealed.
Genetic risk for RA associated with early cognitive symptoms in children
Having an increased genetic risk for rheumatoid arthritis is associated with demonstrating hyperactivity and inattention symptoms from ages 4 to 16 years, as well as lower total IQ and IQ performance at 8 years, according to data published in JAMA Network Open.
Methylphenidate treatment may not increase risk for psychotic events
Results from a large population-based cohort study in Sweden showed no evidence that initiation of methylphenidate treatment increased the risk for psychotic events among teenagers and young adults, including among those with a history of psychosis.
How to address nonmedical stimulant use among college-aged patients
SAN FRANCISCO — In a session presented here, Anthony L. Rostain, MD, MA, professor of psychiatry and pediatrics and Adult ADHD Treatment and Research Program Perelman School of Medicine, University of Pennsylvania medical director, spoke about the non-medical use and abuse of prescription stimulant medications.
Methylphenidate treatment for ADHD tied to several types of insomnia
Methylphenidate use was significantly associated with sleep problems and several different types of insomnia, according to a meta-analysis published in Journal of Clinical Psychiatry.
Top stories to read during Mental Health Awareness Month
Although millions of individuals in the United States are affected by mental health conditions, stigma can prevent people receiving the care and attention they need.
Many adolescents have mental disorders at the time of transition into adulthood
A Danish nationwide birth cohort study showed that the incidence rates of any mental disorder, substance use disorders, depression and anxiety disorders increased substantially by adolescence.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read